The Dawning of a New Era in the Management of Prurigo Nodularis: A Focus on the Patient Experience, Differential Diagnosis and Emerging Treatment Options Evaluation (ID: i833-3) Survey

Question Title

* 1. How many patients with PN do you manage per month?

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

Question Title

* 2. After participating in this activity, how confident are you in the management of patients with PN in your practice?

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 3. How committed are you to making changes in your practice based on your participation in this activity? 

Very committed

Committed

Neutral

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason

Question Title

* 4. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information I can apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

Question Title

* 5. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Asking more detailed and specific questions about the impact of PN on the patient’s quality of life

Selecting a treatment that will target inflammatory drivers of PN

EADV major criteria to evaluate patients who have nodular/papular skin manifestations that appear to resemble PN

Selecting a treatment based on clinical trial findings of reduction in itch and improvement in lesion healing

Question Title

* 6. What barriers do you see to making changes in your practice? Please select all that apply.

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement, or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

Question Title

* 7. Please rate your level of agreement by checking the appropriate rating.

Sonja Ständer, MD, effectively:

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Presented the Material	Presented the Material Strongly Agree	Presented the Material Agree	Presented the Material Neutral	Presented the Material Disagree	Presented the Material Strongly Disagree
Avoided Commercial Bias	Avoided Commercial Bias Strongly Agree	Avoided Commercial Bias Agree	Avoided Commercial Bias Neutral	Avoided Commercial Bias Disagree	Avoided Commercial Bias Strongly Disagree

Question Title

* 8. Please rate your level of agreement by checking the appropriate rating.

Gil Yosipovitch, MD, effectively:

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Presented the Material	Presented the Material Strongly Agree	Presented the Material Agree	Presented the Material Neutral	Presented the Material Disagree	Presented the Material Strongly Disagree
Avoided Commercial Bias	Avoided Commercial Bias Strongly Agree	Avoided Commercial Bias Agree	Avoided Commercial Bias Neutral	Avoided Commercial Bias Disagree	Avoided Commercial Bias Strongly Disagree

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating.

The educational activity:

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Met the identified learning objectives	Met the identified learning objectives Strongly Agree	Met the identified learning objectives Agree	Met the identified learning objectives Neutral	Met the identified learning objectives Disagree	Met the identified learning objectives Strongly Disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly Agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly Disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly Agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly Disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly Agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly Disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly Agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly Disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly Agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly Disagree

Question Title

* 10. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 11. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for prurigo nodularis:

Question Title

* 1. How many patients with PN do you manage per month?

Question Title

* 2. After participating in this activity, how confident are you in the management of patients with PN in your practice?

Question Title

* 3. How committed are you to making changes in your practice based on your participation in this activity?

Question Title

* 4. Which of the following best describes the impact of this activity on your performance?

Question Title

* 5. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.

Question Title

* 6. What barriers do you see to making changes in your practice? Please select all that apply.

Question Title

* 7. Please rate your level of agreement by checking the appropriate rating.Sonja Ständer, MD, effectively:

Question Title

* 8. Please rate your level of agreement by checking the appropriate rating.Gil Yosipovitch, MD, effectively:

Question Title

* 9. Please rate your level of agreement by checking the appropriate rating.The educational activity:

Question Title

* 10. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?

Question Title

* 11. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for prurigo nodularis:

Question Title

* 12. If you indicated that you perceived commercial bias or influence, please describe:

* 3. How committed are you to making changes in your practice based on your participation in this activity? 

* 7. Please rate your level of agreement by checking the appropriate rating.

Sonja Ständer, MD, effectively:

* 8. Please rate your level of agreement by checking the appropriate rating.

Gil Yosipovitch, MD, effectively:

* 9. Please rate your level of agreement by checking the appropriate rating.

The educational activity: